Stock listing
ZLD Stock Price, News, Filings & Events — Zelira Therapeutics Ltd.
Selected listing: ZLD · ASX · AUD · AU
This page tracks Zelira Therapeutics Ltd.'s ZLD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZLD:ASX. ZLD:ASX is the stock-level entry point for investors researching Zelira Therapeutics Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zelira Therapeutics Ltd. is a public company listed on the Australian market under the ticker ZLD. The company has a market capitalization of approximately AUD 4.16 million. Zelira focuses on developing and commercializing cannabinoid-based therapies.

- Ticker
- ZLD:ASX
- Asset type
- Stock
- Market cap
- $4.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- ASX
- Currency
- AUD
Zelira Therapeutics Ltd. ZLD:ASX stock context
This page tracks Zelira Therapeutics Ltd.'s ZLD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZLD:ASX. ZLD:ASX is the stock-level entry point for investors researching Zelira Therapeutics Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zelira Therapeutics Ltd. is a public company listed on the Australian market under the ticker ZLD. The company has a market capitalization of approximately AUD 4.16 million. Zelira focuses on developing and commercializing cannabinoid-based therapies.
Latest news from Zelira Therapeutics Ltd.
Research Zelira Therapeutics Ltd.
Zelira Therapeutics Ltd. investor report
Review AI stock analysis and investor report context for ZLD:ASX.
Zelira Therapeutics Ltd. company profile
View the public company page for Zelira Therapeutics Ltd. on 6ix.
Zelira Therapeutics Ltd. news
Read company news and market updates connected to Zelira Therapeutics Ltd..
Zelira Therapeutics Ltd. investor events
Find investor webinars, events, and replay context for Zelira Therapeutics Ltd..
Alternate listings
ZLDAF:OTC
US · USD
Alternate listing for Zelira Therapeutics Ltd.; the primary context on this page is ZLD:ASX.
A2AS5H:LSX
DE · EUR
Alternate listing for Zelira Therapeutics Ltd.; the primary context on this page is ZLD:ASX.
A2AS5H:LS
DE · EUR
Alternate listing for Zelira Therapeutics Ltd.; the primary context on this page is ZLD:ASX.
G1G:DUS
DE · EUR
Alternate listing for Zelira Therapeutics Ltd.; the primary context on this page is ZLD:ASX.
G1G:FWB
DE · EUR
Alternate listing for Zelira Therapeutics Ltd.; the primary context on this page is ZLD:ASX.
G1G:SWB
DE · EUR
Alternate listing for Zelira Therapeutics Ltd.; the primary context on this page is ZLD:ASX.